Racial differences in renal replacement therapy initiation among children with a nonglomerular cause of chronic kidney disease

被引:34
|
作者
Ng, Derek K. [1 ]
Moxey-Mims, Marva [2 ]
Warady, Bradley A. [3 ]
Furth, Susan L. [4 ,5 ]
Munoz, Alvaro [1 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[2] NIDDK, NIH, Bethesda, MD 20892 USA
[3] Childrens Mercy Hosp, Div Pediat Nephrol, Kansas City, MO 64108 USA
[4] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA
[5] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
关键词
Pediatric nephrology; Chronic kidney disease; Health disparities; Renal replacement therapy; Inverse probability weights; MARGINAL STRUCTURAL MODELS; GLOMERULAR-FILTRATION-RATE; SOCIOECONOMIC-STATUS; AFRICAN-AMERICANS; RACE DISPARITIES; TRANSPLANTATION; ACCESS; PROGRESSION; APOL1; STAGE;
D O I
10.1016/j.annepidem.2016.09.011
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose: African American (AA) adults with chronic kidney disease (CKD) have a faster progression to end-stage renal disease and are less likely to receive a kidney transplant. It is unclear whether AA children experience renal replacement therapy (RRT) for end-stage renal disease sooner than non-AA children after accounting for socioeconomic status (SES). Methods: Among children with nonglomerular CKD in the Chronic Kidney Disease in Children study, we investigated time to RRT (i.e., first dialysis or transplant) after CKD onset using parametric survival models and accounted for SES differences by inverse probability weights. Results: Of 110 AA and 493 non-AA children (median age = 10 years), AA children had shorter time to first RRT: median time was 3.2 years earlier than non-AA children (95% CI:-6.1,-0.3). When accounting for SES, this difference was diminished and nonsignificant (-1.6 years; 95% CI:-4.6, +1.5), and its directionality was consistent with faster glomerular filtration rate decline among AA children (-6.2% vs.-4.4% per year, P =.098). When RRT was deconstructed into dialysis or transplant, the time to dialysis was 37.5% shorter for AA children and 53.7% longer for transplant. These inferences were confirmed by the frequency and timing of transplant after initiating dialysis. Conclusions: Racial differences in time to RRT were almost fully accounted for by SES, and the remaining difference was congruent with a faster glomerular filtration rate decline among AA children. Access to transplant occurred later, yet times to dialysis were shorter among AA children even when accounting for SES which may be due to a lack of organ availability. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:780 / 787
页数:8
相关论文
共 50 条
  • [31] The Timing of Renal Replacement Therapy Initiation in Acute Kidney Injury
    Wald, Ron
    Bagshaw, Sean M.
    SEMINARS IN NEPHROLOGY, 2016, 36 (01) : 78 - 84
  • [32] Association of Fitness With Racial Differences in Chronic Kidney Disease
    Paluch, Amanda E.
    Pool, Lindsay R.
    Isakova, Tamara
    Lewis, Cora E.
    Mehta, Rupal
    Schreiner, Pamela J.
    Sidney, Stephen
    Wolf, Myles
    Carnethon, Mercedes R.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2019, 57 (01) : 68 - 76
  • [33] PREDICTING MORTALITY BEFORE RENAL REPLACEMENT THERAPY IN CHRONIC KIDNEY DISEASE PATIENTS
    Lees, Jennifer
    Gillis, Keith
    Jardine, Alan
    Mark, Patrick
    Traynor, Jamie
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [34] Evolving Trends in Clinical Presentation of and Renal Replacement Therapy for Chronic Kidney Disease
    Ansell, David
    Tomson, Charles R. V.
    NEPHRON CLINICAL PRACTICE, 2009, 111 (04): : C265 - C267
  • [35] EFFECTS OF RENAL REPLACEMENT THERAPY ON FIBROMYALGIA SYNDROME IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Berber, Ilhami
    Sahin, Idris
    Gorgel, Ahmet
    Cagin, Yasir Furkan
    Bag, Harika Gozukara
    Berber, Nurcan Kirici
    ACTA MEDICA MEDITERRANEA, 2018, 34 (02): : 337 - 343
  • [36] CHRONIC KIDNEY DISEASE IS NOT CHARACTERISED SOLELY BY THOSE STARTING RENAL REPLACEMENT THERAPY
    Adegbija, O.
    Hoy, W. E.
    Wang, Z.
    Cameron, A.
    Healy, H. G.
    Tan, K. S.
    Venuthurupalli, S. K.
    NEPHROLOGY, 2018, 23 : 24 - 25
  • [37] Renal replacement therapy for stage 5 chronic kidney disease in the Cayman Islands
    Cawich, Shamir O.
    Iheonunekwu, Nelson
    Hendriks, Frits
    Hoeksema, Greg
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2010, 42 (02) : 461 - 464
  • [38] The effects of chronic kidney disease and renal replacement therapy on circulating dendritic cells
    Hesselink, DA
    Betjes, MGH
    Verkade, MA
    Athanassopoulos, P
    Baan, CC
    Weimar, W
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (09) : 1868 - 1873
  • [39] Natriuretic Peptides in Chronic Kidney Disease and During Renal Replacement Therapy: An Update
    Khalifeh, Neda
    Haider, Dominik
    Hoerl, Walter H.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2009, 57 (01) : 33 - 39
  • [40] Natriuretic peptides in acute and chronic kidney disease and during renal replacement therapy
    Hörl, WH
    JOURNAL OF INVESTIGATIVE MEDICINE, 2005, 53 (07) : 366 - 370